10'-fluorinated vinca alkaloids provide enhanced biological activity against MDR cancer cells

Details for Australian Patent Application No. 2011218391 (hide)

Owner The Scripps Research Institute

Inventors Boger, Dale L.

Agent Freehills

Pub. Number AU-A-2011218391

PCT Pub. Number WO2011/103007

Priority 61/306,786 22.02.10 US

Filing date 9 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 471/14 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61P 35/00 Antineoplastic agents

C07D 471/12 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/103007 Priority application(s): WO2011/103007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218400-Network centric power flow control

2011218382-Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities